Bob Wynalek is the Chief Operating Officer, Chief Commercialization Officer, and Board Director at DiscGenics, Inc. He is a medical device and biopharma professional and entrepreneur with 35 years' experience within the Regenerative Medicine, Spine, Neurosurgical, and Orthopedic markets. Mr. Wynalek has successfully built and re-built organizations, inclusive of experience with early-stage organizations. He has executive and functional leadership experience in general management, sales, marketing, product development, business development, clinical, and operations disciplines.